• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经网络模型在生物药剂学药物处置分类系统(BDDCS)中预测药物溶解度和代谢类别的应用。

Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).

机构信息

Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran.

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):1-6. doi: 10.1007/s13318-023-00861-5. Epub 2023 Oct 21.

DOI:10.1007/s13318-023-00861-5
PMID:37864650
Abstract

BACKGROUND AND OBJECTIVE

The biopharmaceutics drug disposition classification system (BDDCS) categorizes drugs into four classes on the basis of their solubility and metabolism. This framework allows for the study of the pharmacokinetics of transporters and enzymatic metabolization on biopharmaceuticals, as well as drug-drug interactions in the body. The objective of the present study was to develop computational models by neural network models and structural parameters and physicochemical properties to estimate the class of a drug in the BDDCS system.

METHODS

In this study, deep learning methods were utilized to explore the potential of artificial and convolutional neural networks (ANNs and CNNs) in predicting the BDDCS class of 721 substances. The structural parameters and physicochemical properties [Abraham solvation parameters, octanol-water partition (log P) and over the pH range 1-7.5 (log D), number of rotatable bonds, hydrogen bond acceptor numbers, as well as hydrogen bond donor count] are calculated with various software. These compounds were then split into a training set consisting of 602 molecules and a test set of 119 compounds to validate the models.

RESULTS

The results of this study showed that neural network models using applied parameters of the drug, i.e., log D and Abraham solvation parameters, are able to predict the class of solubility and metabolism in the BDDCS system with good accuracy.

CONCLUSIONS

Neural network models are well equipped to deal with the relations between the structural parameters and physicochemical properties of drugs and BDDCS classes. In addition, log D is a more suitable parameter compared with log P in predicting BDDCS.

摘要

背景与目的

基于药物的溶解度和代谢情况,生物药剂学药物处置分类系统(BDDCS)将药物分为四类。该框架允许研究生物制药中的转运体和酶代谢的药代动力学,以及体内的药物相互作用。本研究的目的是通过神经网络模型和结构参数及物理化学性质建立计算模型,以预测 BDDCS 系统中药物的类别。

方法

本研究利用深度学习方法探索人工神经网络(ANNs)和卷积神经网络(CNNs)在预测 721 种物质的 BDDCS 类别方面的潜力。利用各种软件计算结构参数和物理化学性质[Abraham 溶剂化参数、辛醇-水分配系数(log P)和 pH 值 1-7.5 范围内的分配系数(log D)、可旋转键的数量、氢键受体数以及氢键供体数]。然后,将这些化合物分为包含 602 个分子的训练集和包含 119 个化合物的测试集,以验证模型。

结果

本研究结果表明,使用药物应用参数(即 log D 和 Abraham 溶剂化参数)的神经网络模型能够很好地预测 BDDCS 系统中的溶解度和代谢类别。

结论

神经网络模型能够很好地处理药物的结构参数和物理化学性质与 BDDCS 类别之间的关系。此外,与 log P 相比,log D 更适合用于预测 BDDCS。

相似文献

1
Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).神经网络模型在生物药剂学药物处置分类系统(BDDCS)中预测药物溶解度和代谢类别的应用。
Eur J Drug Metab Pharmacokinet. 2024 Jan;49(1):1-6. doi: 10.1007/s13318-023-00861-5. Epub 2023 Oct 21.
2
Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.基于结构参数预测生物制药药物处置分类系统(BDDCS)。
J Pharm Pharm Sci. 2019;22(1):247-269. doi: 10.18433/jpps30271.
3
BDDCS class prediction for new molecular entities.新型分子实体的 BDDCS 类别预测。
Mol Pharm. 2012 Mar 5;9(3):570-80. doi: 10.1021/mp2004302. Epub 2012 Feb 7.
4
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.pH 依赖性溶解度和渗透性标准在早期药物发现中的临时生物药剂学分类(BCS 和 BDDCS)。
Mol Pharm. 2012 May 7;9(5):1199-212. doi: 10.1021/mp2004912. Epub 2012 Apr 26.
5
Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).根据生物药剂学药物处置分类系统(BDDCS)对作为药物来源的天然产物进行分类。
Chin J Nat Med. 2016 Dec;14(12):888-897. doi: 10.1016/S1875-5364(17)30013-4.
6
BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.生物药剂学分类系统(BDDCS)预测、BDDCS分类的自我修正方面、BDDCS分类修正以及175多种其他药物的分类
AAPS J. 2016 Jan;18(1):251-60. doi: 10.1208/s12248-015-9845-2. Epub 2015 Nov 20.
7
State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.生物药剂学药物处置分类系统(BDDCS)的最新进展及其应用:新增内容、修订和引用参考文献。
AAPS J. 2022 Feb 23;24(2):37. doi: 10.1208/s12248-022-00687-0.
8
BDDCS applied to over 900 drugs.BDDCS 应用于超过 900 种药物。
AAPS J. 2011 Dec;13(4):519-47. doi: 10.1208/s12248-011-9290-9. Epub 2011 Aug 5.
9
Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.通过应用生物药剂学药物处置分类系统预测药物处置。
Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):162-7. doi: 10.1111/j.1742-7843.2009.00498.x. Epub 2009 Dec 7.
10
A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.生物药剂学分类系统与生物药剂学药物处置分类系统的比较分析:一项涉及 500 项生物等效性研究的横断面调查。
J Pharm Sci. 2013 Sep;102(9):3136-44. doi: 10.1002/jps.23515. Epub 2013 Apr 11.

本文引用的文献

1
State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.生物药剂学药物处置分类系统(BDDCS)的最新进展及其应用:新增内容、修订和引用参考文献。
AAPS J. 2022 Feb 23;24(2):37. doi: 10.1208/s12248-022-00687-0.
2
Validating ADME QSAR Models Using Marketed Drugs.利用已上市药物验证 ADME QSAR 模型。
SLAS Discov. 2021 Dec;26(10):1326-1336. doi: 10.1177/24725552211017520. Epub 2021 Jun 26.
3
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
人工智能和机器学习辅助中枢神经系统疾病药物发现:现状与未来方向。
Med Res Rev. 2021 May;41(3):1427-1473. doi: 10.1002/med.21764. Epub 2020 Dec 9.
4
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data.药物发现中的事实、模式和原则:用实测物理化学数据评价 5 规则。
J Med Chem. 2020 Sep 24;63(18):10091-10108. doi: 10.1021/acs.jmedchem.9b01596. Epub 2020 May 11.
5
Is there enough focus on lipophilicity in drug discovery?在药物研发中,对亲脂性的关注是否足够?
Expert Opin Drug Discov. 2020 Mar;15(3):261-263. doi: 10.1080/17460441.2020.1691995. Epub 2019 Nov 17.
6
Can BDDCS illuminate targets in drug design?BDDCS 能否为药物设计照亮目标?
Drug Discov Today. 2019 Dec;24(12):2299-2306. doi: 10.1016/j.drudis.2019.09.021. Epub 2019 Oct 1.
7
Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.基于结构参数预测生物制药药物处置分类系统(BDDCS)。
J Pharm Pharm Sci. 2019;22(1):247-269. doi: 10.18433/jpps30271.
8
The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.生物药剂学分类系统(BCS)和生物药剂学药物处置分类系统(BDDCS):超越指南。
Int J Pharm. 2019 Jul 20;566:264-281. doi: 10.1016/j.ijpharm.2019.05.041. Epub 2019 May 17.
9
Convolutional neural networks: an overview and application in radiology.卷积神经网络:概述及其在放射学中的应用。
Insights Imaging. 2018 Aug;9(4):611-629. doi: 10.1007/s13244-018-0639-9. Epub 2018 Jun 22.
10
Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.用于多靶点药物设计的计算机辅助药物设计:构效关系/定量构效关系、分子对接和药效团方法。
Curr Drug Targets. 2017;18(5):556-575. doi: 10.2174/1389450117666160101120822.